Wintest
6721
Showcase
3909
Beauty Kadan Holdings
3041
Cybozu
4776
KODAMA CHEMICAL INDUSTRY
4222
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.00%1.77T | 1.36%6.91T | 5.62%1.85T | 0.27%1.72T | -3.84%1.67T | 3.48%1.67T | 24.07%6.82T | 12.77%1.75T | 22.37%1.72T | 36.18%1.74T |
Cost of revenue | 4.55%1.43T | -0.27%5.57T | 2.50%1.48T | -1.93%1.39T | -4.90%1.34T | 3.41%1.36T | 24.47%5.58T | 12.36%1.44T | 23.18%1.41T | 37.50%1.41T |
Gross profit | 12.45%344.9B | 8.73%1.34T | 20.32%368.12B | 10.58%334.69B | 0.72%332.96B | 3.78%306.71B | 22.30%1.23T | 14.72%305.96B | 18.74%302.67B | 30.83%330.58B |
Operating expense | 12.37%246.28B | 17.50%957.63B | 20.39%271.49B | 18.05%242.66B | 15.07%224.29B | 15.97%219.18B | 23.85%814.98B | 61.36%225.52B | 12.78%205.56B | 13.83%194.91B |
Selling and administrative expenses | 12.57%246.4B | 14.27%927.59B | 11.84%252.4B | 15.95%234.87B | 13.35%221.45B | 16.33%218.88B | 13.70%811.74B | 13.04%225.67B | 11.72%202.56B | 16.97%195.36B |
-General and administrative expense | 12.57%246.4B | 14.27%927.59B | 11.84%252.4B | 15.95%234.87B | 13.35%221.45B | 16.33%218.88B | 13.70%811.74B | 13.04%225.67B | 11.72%202.56B | 16.97%195.36B |
Other operating expenses | -138.33%-115M | 826.60%30.03B | 12,261.78%19.09B | 159.46%7.79B | 734.30%2.85B | -64.50%300M | 105.80%3.24B | 99.74%-157M | 212.06%3B | -110.66%-449M |
Operating profit | 12.67%98.62B | -8.32%384.86B | 20.12%96.63B | -5.23%92.03B | -19.90%108.67B | -17.85%87.53B | 19.41%419.77B | -36.63%80.45B | 33.70%97.11B | 66.56%135.67B |
Net non-operating interest income (expenses) | -3.36%-4.73B | -42.47%-16.31B | 61.03%-2.28B | -33.36%-3.76B | -158.60%-5.7B | -690.85%-4.58B | -850.29%-11.45B | -9,187.30%-5.85B | -94,033.33%-2.82B | -445.30%-2.2B |
Non-operating interest income | 13.12%17.67B | 48.97%72.01B | 45.59%20.52B | 34.28%18.49B | 57.29%17.39B | 65.74%15.62B | 66.75%48.34B | 53.93%14.09B | 84.49%13.77B | 72.25%11.05B |
Non-operating interest expense | 10.91%22.4B | 47.73%88.33B | 14.31%22.8B | 34.13%22.25B | 74.12%23.08B | 101.92%20.2B | 98.02%59.79B | 116.35%19.94B | 122.33%16.59B | 94.34%13.26B |
Net investment income | 13.03%5.34B | -31.86%13.68B | 186.16%1.57B | -53.50%4.57B | -17.92%2.81B | -24.64%4.72B | -26.37%20.07B | -96.71%549M | 140.27%9.83B | 155.75%3.43B |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 421.07%5.15B | -87.23%3.71B | -90.87%691M | -17.68%917M | 29.26%3.71B | -109.17%-1.6B | -39.78%29.05B | -76.16%7.57B | -64.87%1.11B | -72.74%2.87B |
Income from associates and other participating interests | -14.18%62.43B | -31.70%172.37B | -182.60%-41.02B | 17.47%61.15B | 0.70%79.5B | 1.42%72.74B | 42.73%252.39B | 974.89%49.66B | 5.14%52.06B | 19.22%78.95B |
Special income (charges) | -54.52%136M | -330.68%-30.66B | -186.92%-30.65B | 203.12%496M | -103.40%-806M | -58.87%299M | 205.13%13.29B | 30.21%-10.68B | 79.91%-481M | 1,465.11%23.73B |
Less:Impairment of capital assets | 315,400.00%3.16B | 445.28%37.41B | 173.38%32.11B | 281.43%4.42B | 114.81%888M | 102.17%1M | -61.64%6.86B | -16.92%11.74B | -69.61%1.16B | -29,875.00%-6B |
Less:Other special charges | -997.00%-3.29B | 66.49%-6.75B | -37.19%-1.46B | -625.70%-4.91B | 99.54%-82M | 55.95%-300M | -284.29%-20.15B | -190.61%-1.06B | 52.22%-677M | -1,085.29%-17.73B |
Other non-operating income (expenses) | ||||||||||
Income before tax | 4.92%166.93B | -27.03%527.65B | -79.51%24.94B | -0.89%155.41B | -22.38%188.19B | -21.31%159.11B | 22.56%723.12B | -26.08%121.69B | 23.46%156.81B | 50.91%242.44B |
Income tax | 41.86%31.31B | -18.04%101.53B | 173.51%29.26B | -21.30%26.74B | -39.07%23.46B | -45.76%22.07B | 17.47%123.88B | -66.06%10.7B | 23.17%33.98B | 81.40%38.5B |
Net income | -1.03%135.62B | -28.89%426.12B | -103.89%-4.32B | 4.76%128.67B | -19.23%164.73B | -15.14%137.03B | 23.67%599.25B | -16.61%111B | 23.54%122.83B | 46.27%203.94B |
Net income continuous operations | -1.03%135.62B | -28.89%426.12B | -103.89%-4.32B | 4.76%128.67B | -19.23%164.73B | -15.14%137.03B | 23.67%599.25B | -16.61%111B | 23.54%122.83B | 46.27%203.94B |
Noncontrolling interests | 22.16%9.3B | 17.25%39.76B | 33.86%13.44B | 8.06%9.45B | 3.91%9.26B | 22.47%7.61B | 62.48%33.91B | 120.76%10.04B | 64.02%8.74B | 56.68%8.92B |
Net income attributable to the company | -2.40%126.32B | -31.66%386.35B | -117.59%-17.75B | 4.50%119.22B | -20.28%155.47B | -16.65%129.42B | 21.92%565.33B | -21.47%100.96B | 21.24%114.08B | 45.83%195.02B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -2.40%126.32B | -31.66%386.35B | -117.59%-17.75B | 4.50%119.22B | -20.28%155.47B | -16.65%129.42B | 21.92%565.33B | -21.47%100.96B | 21.24%114.08B | 45.83%195.02B |
Gross dividend payment | ||||||||||
Basic earnings per share | -1.65%103.86 | -30.21%315.87 | -117.76%-14.45 | 6.94%97.54 | -18.42%127.2 | -14.94%105.6 | 22.07%452.63 | -20.87%81.35 | 21.23%91.21 | 45.80%155.92 |
Diluted earnings per share | -1.64%103.78 | -30.21%315.64 | -117.78%-14.45 | 6.95%97.47 | -18.42%127.12 | -14.95%105.51 | 22.06%452.27 | -20.89%81.25 | 21.21%91.14 | 45.79%155.83 |
Dividend per share | 0 | 8.70%125 | 8.70%62.5 | 0 | 8.70%62.5 | 0 | 4.55%115 | -11.54%57.5 | 0 | 27.78%57.5 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |